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A first national snapshot
Acute kidney injury (AKI) is increasing in incidence 
globally. This report presents the first national statistical 
snapshot on AKI and its impact in Australia. The key 
findings show that AKI accounts for a considerable 
number of hospitalisations and deaths and further, that 
the burden of this condition is not equally distributed 
across the Australian population. These inequalities 
were seen in relation to all population characteristics 
examined, namely sex and age, remoteness of residence, 
socioeconomic disadvantage and Indigenous status.
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Summary
Acute kidney injury (AKI) is increasing in incidence globally. This report presents the first 
national statistical snapshot on AKI and its impact in Australia. 
Australian hospital and mortality data have been used to assess the burden of AKI. This report 
examines AKI as both the main and/or an associated cause of hospitalisations and deaths to 
present a more complete picture of the burden of AKI in Australia. The key findings highlight 
the substantial hospitalisations and deaths associated with AKI and the related inequalities that 
exist in the Australian population.
In 2012–13, there were around 131,780 hospitalisations for AKI (as the 
principal and/or an additional diagnosis). The average length of stay for 
AKI hospitalisations was 11.4 days, which was twice as long as the average 
length of stay for hospitalisations overall (5.6 days).
In 2012, there were around 5,160 deaths where AKI was recorded as the 
underlying or an associated cause of death.
AKI hospitalisations (as a principal diagnosis) more than doubled between 
2000–01 and 2012–13 (from 8,050 to 18,010), an average increase of 6%  
per year. Despite this large increase in AKI hospitalisations, deaths due to 
AKI have remained relatively similar over the last decade (an average of 
4,670 deaths per year between 2000 and 2012).
Hospitalisation and death rates for AKI increase rapidly with age, with 
the majority occurring in those aged 65 and over. For example, AKI 
hospitalisations for those aged 85 and over were at least 4 times those in  
the 65–74 age group. 
Males had higher rates of AKI hospitalisations (as an additional diagnosis) 
and deaths than females (at least 40% higher). For hospitalisations with a 
principal diagnosis of AKI, rates for males and females were similar. 
Those living in Very remote areas of Australia generally have a higher 
burden of AKI. For hospitalisations for AKI as a principal diagnosis and for 
AKI deaths, people living in Very remote areas had hospitalisation and death 
rates at least 1.5 times as high as those living in Major cities. 
This differed for AKI hospitalisations as an additional diagnosis, where people 
living in Major cities or Very remote areas were hospitalised at around 1.3 times 
the rate of those living in Inner regional, Outer regional and Remote areas.
People living in socioeconomically disadvantaged areas had higher AKI 
hospitalisation and death rates. For hospitalisations for AKI as a principal 
diagnosis, rates in the lowest socioeconomic group were almost twice as 
high as in the highest group. For AKI hospitalisations as an additional 
diagnosis and for AKI deaths—rates were 1.3 times as high in the lowest 
socioeconomic group compared with the highest group.
Aboriginal and Torres Strait Islander status was associated with higher 
hospitalisation and mortality rates. Hospitalisation and death rates for AKI 
were at least twice as high among Indigenous Australians compared to 
Other Australians/non-Indigenous Australians.
v
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1 Introduction 
About acute kidney injury 
Acute kidney injury (AKI) is a common, often under-recognised disorder that is increasing in 
incidence globally, and is strongly associated with increased early and long-term morbidity 
and mortality (Lewington et al. 2013). It is a condition that occurs when there is an abrupt 
loss of kidney function to the point where the body accumulates waste products and 
becomes unable to maintain electrolyte, acid-base and water balance (Togel & Westenfelder 
2014). Clinically, it is measured and diagnosed by an acute rise of serum creatinine and/or 
decline in urine output, caused by an acute fall in the glomerular filtration rate (Lewington et 
al. 2013).  
Causes and risk factors 
AKI has a broad range of causes including various kidney diseases but is frequently the 
consequence of injury or trauma from restriction of blood supply to the tissues or as a result 
of extreme inflammation (for example with sepsis) (Togel & Westenfelder 2014). It can be 
acquired in the community (for example from specific infections or toxins) or in hospital. In 
developed countries such as Australia, AKI is predominantly diagnosed in the general 
hospitalised population, critically ill patients admitted to intensive care units (ICUs), and 
those receiving radiocontrast agents (substances commonly used to enhance the visibility of 
blood vessels) for cardiovascular-related surgery. As a result, AKI is mainly seen in the 
context of sepsis, multi-organ failure and post-cardiovascular procedures or as a 
complication of medications. While AKI occurs among all age groups, it is particularly 
prominent among older patients with substantial comorbidities (Lewington et al. 2013).  
AKI risk factors include older age, diabetes, hypertension, obesity and cardiovascular 
disease. Further, pre-existing chronic kidney disease (CKD) has been found to be the most 
important risk factor for the development of AKI (Chawla et al. 2014). 
The relationship between AKI and CKD 
As noted above, CKD is a risk factor for AKI. However, several studies have also provided 
considerable evidence to suggest that AKI is an independent risk factor for CKD (Lewington 
et al. 2013) (Figure 1.1). Pre-existing CKD has been found to increase the risk of AKI by as 
much as 10 times (Chawla et al. 2014). Multiple studies have found evidence that AKI is not 
only directly linked to the progression of CKD but causes CKD as well. Further, both AKI 
and CKD are risk factors for cardiovascular disease (Chawla et al. 2014). 
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Note: Modified from Chawla et al. 2014. 
Source: KDIGO 2012.  
Figure 1.1: Acute kidney injury and chronic kidney disease as an interconnected syndrome 
The impact of AKI 
AKI has a variety of short- and long-term outcomes ranging from complete recovery of 
kidney function, through to mild degrees of chronic kidney disease, severe kidney damage 
leading to long-term dialysis dependency, and death (including increased short-term risk for 
in-hospital death). The severity and duration of the event heavily influence these outcomes 
(Lewington et al. 2013). Patients with severe forms of AKI requiring short-term dialysis are 
particularly at increased risk for the long-term development or acceleration of pre-existing 
CKD, resulting in end-stage kidney disease (ESKD) and long-term dialysis therapy 
(Koulouridis et al. 2014). Given that AKI often results in prolonged hospitalisation and a 
high need for post-acute care, this condition is associated with high resource consumption. 
There is increasing recognition of the impact that AKI has on the individual patient and the 
major economic burden its long-term effects have on society. 
Defining AKI 
AKI, previously known as acute kidney failure, has undergone significant re-examination in 
the last decade. Until recently, there were multiple definitions for the clinical 
definition/diagnostic criteria for AKI with no consensus (see Box 1.1). The shift in 
terminology from acute kidney failure to acute kidney injury occurred to encompass the 
entire spectrum of the syndrome, from minor changes in kidney function to kidney failure 
(KDIGO 2012). Although efforts to standardise the definition of AKI have come a long way, 
the concept of AKI is still evolving.   
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Box 1.1: History of acute kidney injury definitions 
Until recently, there was no consensus on the clinical definition or diagnostic criteria of AKI 
(previously known as acute kidney failure). The lack of a standardised definition made it 
difficult to determine the epidemiology and outcomes of AKI, leading to wide variations in 
the reported incidence of AKI (Lewington & Kanagasundaram 2011).  
In 2004, to address the lack of a universal definition for AKI, the Acute Dialysis Quality 
Initiative (ADQI)* produced the first consensus definition of AKI. They devised the Risk, 
Injury, Failure, Loss of kidney function and End-stage kidney disease (RIFLE) definition 
and staging system. RIFLE defined AKI as a rise in creatinine of ≥50% from its baseline 
value and/or a fall in the glomerular filtration rate (GFR) by ≥25%, and/or a decrease in 
urine output below 0.5 ml/kg/h for 6 hours or more (Thomas et al. 2014). This was an 
important step towards providing a standard by which comparative epidemiology and 
clinical outcomes could be judged (Pickering & Endre 2014).  
In 2006, the Acute Kidney Injury Network (AKIN)* revised this definition. AKI replaced the 
term acute kidney failure to include the entire spectrum of kidney injury, from minor to 
more advanced forms when acute kidney failure may require renal replacement therapy 
(RRT) (Lewington & Kanagasundaram 2011). The AKIN definition introduced an absolute 
change in creatinine of ≥0.3 mg/dl (≥26.4 umol/l) within 48 hours, as well as an increase in 
creatinine of 50%, and the change in GFR was omitted entirely in the definition for AKI 
(Pickering & Endre 2014). This modification was included to reflect the increasing 
recognition of the clinical significance of relatively small rises in serum creatinine 
(Lewington & Kanagasundaram 2011).  
In 2012, Kidney Disease: Improving Global Outcomes (KDIGO)* produced a definition and 
staging system that combined both previous definitions and staging systems that ADQI and 
AKIN proposed (Lewington & Kanagasundaram 2011). The KDIGO definition defines AKI 
by a ≥0.3 mg/dl increase in creatinine or a 50% increase above baseline within 48 hours, or a 
≥50% increase in creatinine above baseline within 7 days (Pickering & Endre 2014).  
Despite the significant contribution of these definitions towards the diagnosis and 
management of AKI, they have limitations. As a result, there are currently efforts to further 
refine the definition of AKI (Thomas et al. 2014). 
 
*ADQI, AKIN, and KDIGO are international, interdisciplinary organisations. 
National monitoring of AKI 
Given the broad nature of this disorder, the incidence of AKI has been shown to vary widely 
across studies and is greatly dependent on the setting (hospital- vs. community-acquired) 
and the at-risk population investigated. Despite this, over the last decade, dramatic rises in 
the prevalence and incidence of AKI have been reported worldwide (Li et al. 2013; Siew & 
Davenport 2014).   
Monitoring the direct or indirect impact of AKI is critical to better understand the syndrome 
and its burden on society. It is also needed to inform health-care policy and service planning, 
as well as evaluating progress in disease prevention and management. While individual 
cohort studies have been undertaken, there are currently no published national or 
jurisdictional reports on the burden and impact of AKI in Australia. Hence, it is intended 
that this report will contribute to filling this important information gap.  
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A diagnosis of AKI is captured in national hospital and mortality statistics, using defined 
codes based on the World Health Organization’s International Statistical Classification of 
Diseases and Related Health Problems (ICD). Therefore, the AIHW National Morbidity 
Database and AIHW National Mortality Database can be used to assess the impact of AKI in 
Australia (see Appendix A for further details). A broad range of the ICD-10-AM/ICD-10 
codes define AKI, including N17–Acute kidney failure; N00–Acute nephritic syndrome; 
N10–Acute tubulo-interstitial nephritis; and E10.29, E11.29, E13.29, E14.29–Diabetes with 
other specific kidney complication including acute kidney failure. Note that the majority of 
AKI cases are N17 (see Appendix A: tables A1 and A3). However, given that the clinical 
definition/diagnostic criteria for AKI is evolving, defining AKI by these codes may not 
capture all cases of AKI in hospital records and on death certificates.  
Scope of this report 
This is the first national report on hospitalisations and deaths related to AKI in Australia. It 
gives a statistical reference for policy makers, service providers, planners, clinicians and 
researchers.  
This report examines AKI and its impact on hospitalisations and deaths in relation to: sex 
and age, remoteness of residence, socioeconomic disadvantage and Indigenous status. It also 
presents trends and describes the relationship between AKI and CKD. However, it was 
outside the scope of the report to explore the underlying factors that may contribute to 
higher rates of AKI among certain population groups. 
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2  Acute kidney injury hospitalisations 
Acute kidney injury is linked with substantial ill health, in particular hospitalisations. In 
addition to causing hospitalisations, AKI is also a common hospital-acquired disorder, 
particularly among critically ill patients in ICUs (Lewington et al. 2013). Among the known 
causes of hospital-acquired AKI are hospital-acquired infections, sepsis, multi-organ failure 
and complex surgery (Li et al. 2013). Drug-induced kidney injury is also recognised as a 
major factor in hospital-acquired AKI. Further, several studies have highlighted a link 
between AKI events and hospital re-admissions, with one recent study finding that even 
mild episodes of AKI can result in hospital re-admissions (Koulouridis et al. 2014).  
This section aims to describe the impact and assess the burden of all hospitalisations where 
AKI is recorded as a diagnosis (note that it does not look at hospital-acquired AKI 
specifically). The hospitalisation data in this report are sourced from the AIHW National 
Hospital Morbidity Database (NHMD), which records information on admitted patient care 
(separations or hospitalisations) in essentially all hospitals in Australia (see Box 2.1 and 
Appendix A). A range of ICD codes, as shown in Table A1, identify AKI in the NHMD.  
Box 2.1: Defining hospitalisations in this report 
Statistics on admitted patients are compiled when an admitted patient (a patient who 
undergoes a hospital’s formal admission process) completes an episode of admitted patient 
care and ‘separates’ from the hospital. This is because most of the data on the use of 
hospitals by admitted patients are based on information provided at the end of the patient’s 
episodes of care, rather than at the beginning. In this report, a ‘hospitalisation’ (or 
‘separation’) refers to an episode of admitted care, which can be a total hospital stay (from 
admission to discharge, transfer or death) or a portion of a hospital stay beginning or 
ending in a change of type of care (for example, from acute care to rehabilitation). 
Clinical information recorded in the NHMD includes information on principal and 
additional diagnoses: 
• The principal diagnosis is the diagnosis established after study to be chiefly responsible 
for occasioning the patient’s hospitalisation. 
• The additional diagnosis is a condition or complaint that either coexists with the 
principal diagnosis or arises during the hospitalisation. An additional diagnosis is 
reported if the condition affects patient management. 
Characteristics of the person (such as age and sex), length of stay in hospital and the 
outcome of the hospitalisation (discharge of home, transfer to another hospital, or death) 
are also recorded. 
The same person can have multiple hospitalisations. This means that without linking 
records of multiple hospitalisations to individuals (not yet done at the national level), it is 
not possible to count the number of individuals being hospitalised nationally, and their 
patterns of hospitalisation. For this reason, the data presented in this report do not 
represent the number or proportion of people admitted to hospital in Australia with AKI. 
 
For more information, see Appendix A. 
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Given that hospitalisation patterns differed for AKI as the principal diagnosis compared 
with an additional diagnosis, this section reports data for AKI as the principal and/or 
additional diagnosis combined and then separately.  
Acute kidney injury as a principal and/or additional 
diagnosis 
In 2012–13, there were around 131,780 hospitalisations for AKI recorded as the principal 
and/or an additional diagnosis (representing 1.6% of hospitalisations overall†). These 
hospitalisations accounted for around 1.5 million bed days (or 7% of all bed days). The 
average length of stay for AKI hospitalisations was 11.4 days, which was twice as long as the 
average length of stay for hospitalisations overall (5.6 days). Average length of stay refers to 
the average number of days a person spends in hospital; it excludes those who were 
admitted and discharged on the same date. 
The majority (76%) of AKI hospitalisations were coded as ‘Acute kidney failure’ (ICD-10-AM 
code N17), followed by ‘Diabetes with other specified kidney complication including acute 
kidney failure’ (19%) and ‘Acute tubulo-interstitial nephritis’ (3.7%) (see Appendix A: Table 
A1).  
Of hospitalisations involving AKI, it was the principal diagnosis for around 18,010 
hospitalisations (14%) and an additional diagnosis for a further 113,770 (86%). 
Hospitalisations with a principal diagnosis of AKI tended to have diabetes or other kidney 
diseases as an additional diagnosis. This differed for hospitalisations with AKI as an 
additional diagnosis, which tended to have a principal diagnosis of a cardiovascular- or 
respiratory system-related disease. 
Relationship between AKI and CKD hospitalisations 
As mentioned previously, AKI is strongly associated with the subsequent development of 
CKD and the most important risk factor for AKI is pre-existing CKD (Li et al. 2013; Ishani et 
al. 2009; Xue et al. 2006).  
In 2012–13, there were around 56,570 hospitalisations in which AKI and CKD were both 
present as the principal and/or additional diagnosis. Of all AKI-related hospitalisations  
(as the principal and/or an additional diagnosis), 44% also had a diagnosis of CKD. For all 
CKD-related hospitalisations, 22% also had a diagnosis of AKI (Figure 2.1). 
 
                                                     
† Note that the hospitalisation analyses in this report exclude all hospitalisations with dialysis as a principal 
diagnosis (see Appendix A). 
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Note: The ICD-10-AM codes E10.29, E11.29, E13.29, E14.29 and N00 are overlapping codes for AKI and CKD and were excluded from this 
analysis. See Reporting AKI hospitalisations and deaths in Appendix A for further details. 
Source: AIHW National Hospital Morbidity Database. 
Figure 2.1: Hospitalisations for persons with acute kidney injury and/or chronic kidney disease, as 
the principal and/or additional diagnosis, 2012–13  
Acute kidney injury as the principal diagnosis 
In 2012–13, of the 18,010 hospitalisations where AKI was recorded as the principal diagnosis, 
the majority (74%) were coded as ‘Acute kidney failure’ followed by ‘Acute tubulo-
interstitial nephritis’ (23%) (see Appendix A: Table A1).  
Trends 
Between 2000–01 and 2012–13 there has been a considerable increase in the number and rate 
of hospitalisations where AKI was recorded as a principal diagnosis. The number of 
hospitalisations with AKI as a principal diagnosis more than doubled, from 8,050 to 18,010, 
an average increase of around 830 hospitalisations (or 6%) per year over this period.  
Similarly, the age-standardised rate of hospitalisations for AKI increased over the same 
period—by 69% (from 42 to 71 hospitalisations per 100,000 population), an average annual 
increase of 4%.  
The overall increase between 2000–01 and 2012–13 was less for males then females—62% and 
72% respectively (Figure 2.2). The sharp increase in AKI hospitalisations among females 
from 2007–08 was due to high and increasing numbers and rates of ICD-10-AM code N10 
‘Acute tubulo-interstitial nephritis’ (in 2012–13, N10 accounted for 36% of AKI 
hospitalisations in females compared with 8% for males). This increase in N10 among 
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females closed the gap in age-standardised AKI hospitalisations rates between males and 
females from 2007–08 (see Appendix B: Figure B1). The cause of this increase in N10 
hospitalisations is unknown; however, no evidence was found of a change to ICD-10 coding 
rules for N10 during 2007–09.   
 
Note: Age-standardised to the 2001 Australian population. 
Source: AIHW National Hospital Morbidity Database. 
Figure 2.2: Trends in acute kidney injury hospitalisation as the principal diagnosis, by sex, 2000–01 
to 2012–13  
Sex and age 
In 2012–13, males accounted for just under half of AKI hospitalisations (as a principal 
diagnosis) with 8,480 hospitalisations (47%) while females accounted for 53% (9,530 
hospitalisations). However, after adjusting for age, AKI hospitalisation rates were similar for 
males and females (72 and 73 per 100,000 population, respectively). 
Hospitalisation rates for AKI as the principal diagnosis increase rapidly with age, with 60% 
occurring in those aged 65 and over. Rates were highest among those aged 85 and over, and 
were 4 times the rate of those aged 65–74 (744 per 100,000 compared with 178, respectively) 
(Figure 2.3).  
Males had substantially higher rates of hospitalisations for AKI than females among the 
older age groups, with the gap widening with age. For example, males aged 85 and over had 
AKI rates 1.6 times as high as for females (985 compared with 611 per 100,000 respectively), 
compared with 1.4 times as high for those aged 65–74 (210 and 147 per 100,000 respectively) 
(Figure 2.3). However, females had higher rates than males among those aged under 55. 
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Acute tubulo-interstitial nephritis (ICD-10-AM code N10) largely drives the higher rate of 
AKI hospitalisations among females compared with males aged under 55. It accounted for 
76% of AKI hospitalisations in younger females compared with 19% for younger males (N10 
is also higher among females than males in those aged 55 and over but the difference is not 
as large).  
 
Note: See Appendix B: Table B2. 
Source: AIHW National Hospital Morbidity Database. 
Figure 2.3: Acute kidney injury hospitalisations as the principal diagnosis, by age and sex, 2012–13  
Population groups 
Remoteness 
In 2012–13, the hospitalisation rate where AKI was recorded as a principal diagnosis was 
almost twice as high in Very remote areas compared with Major cities. 
The gap in AKI hospitalisation rates between Very remote areas and Major cities was higher 
for females than males—2.3 times as high for females (157 and 68 per 100,000 population, 
respectively) compared with 1.3 times as high for males (90 and 71 per 100,000 population, 
respectively) (Figure 2.4). 
Socioeconomic disadvantage 
In 2012–13, living in an area with socioeconomic disadvantage was associated with higher 
hospitalisation rates where AKI was recorded as the principal diagnosis for both males and 
females (Figure 2.4). Rates in the lowest group were almost twice as high as rates in the 
highest group (92 compared with 53 per 100,000 for males, and 96 and 53 per 100,000 for 
females, respectively), based on area of usual residence. 
Males and females had similar hospitalisation rates for AKI across all socioeconomic groups 
(Figure 2.4). 
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Aboriginal and Torres Strait Islander people  
AKI is a significant contributor to hospitalisations and deaths among Aboriginal and Torres 
Strait Islander people. In 2012–13, the hospitalisation rate for AKI (as the principal diagnosis) 
was almost 3 times as high among Indigenous Australians than Other Australians  
(Figure 2.4). 
Indigenous males were 2.2 times as likely as Other Australian males to be hospitalised for 
AKI as the principal diagnosis (158 and 71 per 1000,000 population, respectively). The 
disparity was even greater for females, with Indigenous females being 3.3 times as likely to 
be hospitalised for AKI as Other Australian females (229 and 70 per 100,000 population, 
respectively). The pattern of greater differences among females than males may in part be 
due to higher rates of CKD among Indigenous females (AIHW 2014c). 
 
Notes 
1. Age-standardised to the 2001 Australian population. 
2. See Appendix B: Table B2.  
3. Other Australians includes people who did not identify as being of Aboriginal and/or Torres Strait Islander origin, and people for whom 
information on their Indigenous status was not available (see Appendix A).  
4. Refer to Appendix A for definitions of classifications for remoteness and socioeconomic groups. 
Source: AIHW National Hospital Morbidity Database. 
Figure 2.4: Acute kidney injury hospitalisations as the principal diagnosis, by sex and selected 
population characteristics, 2012–13 
Acute kidney injury as an additional diagnosis 
In 2012–13, there were around 113,770 hospitalisations for AKI recorded as an additional 
diagnosis. Of these hospitalisations, the majority (77%) were coded as ‘Acute kidney failure’ 
followed by ‘Diabetes with other specified kidney complication including acute kidney 
failure’ (22%) (see Appendix A: Table A1).   
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Sex and age 
Males accounted for over half of all AKI hospitalisations (as an additional diagnosis), 56% 
compared with 44% for females (63,720 and 50,050, respectively). After adjusting for age, 
males had higher AKI hospitalisation rates than females (1.6 times as high; 547 and 346 per 
100,000, respectively). 
As with AKI as the principal diagnosis, hospitalisation rates for AKI as an additional 
diagnosis increase rapidly with age, with those aged 85 and over being hospitalised at 5 
times the rate of those aged 65–74 (6,715 per 100,000 compared with 1,240, respectively). 
Males had higher rates than females across all age groups (Figure 2.5). 
 
Note: See Appendix B: Table B2.   
Source: AIHW National Hospital Morbidity Database. 
Figure 2.5: Acute kidney injury hospitalisations as an additional diagnosis, by age and sex,  
2012–2013  
Population groups 
Remoteness 
In 2012–13, people living in Major cities or Very remote areas were hospitalised at around 1.3 
times the rate for AKI (as the additional diagnosis) as those living in Inner regional, Outer 
regional and Remote areas. Males had higher AKI hospitalisation rates than females, with the 
gap being larger in Major cities, Inner regional and Outer regional areas (around 1.6–1.7 times 
as high). The gap between males and females was less in Remote areas (1.3); and in Very 
remote areas rates were similar for males and females (Figure 2.6). 
Socioeconomic disadvantage 
In 2012–13, living in an area with socioeconomic disadvantage was associated with higher 
hospitalisation rates, where AKI was recorded as the additional diagnosis, for both males 
and females (Figure 2.6). Rates of AKI hospitalisations based on area of usual residence were 
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1.3 times as high in the lowest socioeconomic group compared with the highest 
socioeconomic group. The gap in AKI hospitalisation rates between the lowest and highest 
socioeconomic group was greater for females than males—rates were 1.8 times as high for 
females (441 and 239 per 100,000, respectively) compared to almost 1.6 times for males  
(666 compared with 411 per 100,000, respectively) (Figure 2.6). Males had higher 
hospitalisation rates for AKI across all socioeconomic groups. 
Aboriginal and Torres Strait Islander people 
The rate of hospitalisations where AKI was an additional diagnosis was twice as high among 
Aboriginal and Torres Strait Islander people than Other Australians (866 compared with 429 
per 100,000, respectively).  
Among Indigenous people, AKI hospitalisation rates (as an additional diagnosis) were 
similar for males and females. However, for Other Australians the hospitalisation rates for 
AKI were 1.6 times as high for males as for females (542 compared to 337 per 100,000, 
respectively), reflecting the male and female pattern for AKI hospitalisations overall  
(Figure 2.6).  
 
Notes 
1. Age-standardised to the 2001 Australian population.  
2. See Appendix B: Table B2. 
3. Other Australians includes people who did not identify as being of Aboriginal and/or Torres Strait Islander origin, and people for whom 
information on their Indigenous status was not available (see Appendix A). 
4. Refer to Appendix A for definitions of classifications for remoteness and socioeconomic groups. 
Source: AIHW National Hospital Morbidity Database. 
Figure 2.6: Acute kidney injury hospitalisations as an additional diagnosis, by sex and selected 
population characteristics, 2012–13 
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Principal diagnosis for hospitalisations where AKI is an additional diagnosis 
Where AKI was recorded as an additional diagnosis, the most common principal diagnoses 
were diseases of the circulatory system (cardiovascular disease) (19%) and diseases of the 
respiratory system (12%) (Table 2.1).  
Table 2.1: Hospitalisations with an additional diagnosis of AKI by their principal  
diagnosis, 2012–13 
Principal diagnosis Number of hospitalisations Per cent 
Diseases of the circulatory system 21,852 19.2 
Diseases of the respiratory system 14,088 12.4 
Certain infectious and parasitic diseases 10,474 9.2 
Diseases of the digestive system 9,832 8.6 
Injury and poisoning 9,126 8.0 
Diseases of the genitourinary system 8,218 7.2 
Neoplasms (mainly cancers) 7,402 6.5 
Symptoms, signs and abnormal clinical and laboratory findings 6,428 5.7 
Endocrine, nutritional and metabolic diseases 5,927 5.2 
Rehabilitation 5,721 5.0 
Other 14,700 12.9 
Total 113,768 100.0 
Source: AIHW National Hospital Morbidity Database. 
AKI hospitalisations ending in death 
As previously mentioned, AKI is associated with substantial mortality, including increased 
short-term risk for in-hospital death. There is growing evidence that mild degrees of kidney 
dysfunction, indicated by an increase in serum creatinine, are associated with  increased 
inpatient deaths (Ricci et al. 2008). People with AKI who require dialysis are particularly at 
risk of death, and are the main contributors to high in-hospital AKI-related deaths (Bagshaw 
et al. 2008, Gallagher et al. 2014, Lewington et al. 2013, Ricci et al. 2008).  
In 2012–13, more than 1 in 10 (11%; 14,590) hospitalisations with AKI as a principal or 
additional diagnosis ended in death during the episode of care. For hospitalisations with an 
additional diagnosis of AKI that resulted in death, the principal diagnoses were diseases of 
the circulatory system in almost 1 in 4 cases (23%), followed by diseases of the respiratory 
system (17% of cases), neoplasms (mainly cancer) (14%), certain infectious and parasitic 
diseases (13%) and diseases of the digestive system (12%). 
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3  Acute kidney injury mortality 
AKI is independently associated with increased mortality (Thomas et al. 2014). As the 
severity of AKI increases, so does the rate of death. Further, even after recovery from an AKI 
episode, there is a link between AKI and long-term risk of death (KDIGO 2012).  
The mortality data in this section have been sourced from the AIHW National Mortality 
Database (NMD), which records information on the causes of death in Australia from death 
certificates (see Box 3.1 and Appendix A). It includes deaths occurring both in and out of 
hospital but does not distinguish between these because the NMD does not contain 
information on place of death; the previous chapter supplied information on deaths in 
hospital.  
This section focuses on deaths that can be attributed to AKI by examining deaths with AKI 
reported as the underlying or an associated cause (see Box 3.1). It is known that AKI is 
clinically under-recognised and as a result, may be under-recorded on death certificates 
(Selby et al. 2012). Hence, AKI deaths may be underestimated even when counting those 
with AKI as either the underlying or an associated cause of death. 
Box 3.1: Describing causes of death 
Death certificates document the diseases considered to be instrumental in causing a death. 
A medical practitioner or coroner usually completes these certificates. 
The underlying cause of death is the condition, disease or injury that initiated the sequence of 
events leading directly to death; that is, the primary or main cause. For each death, only a 
single underlying cause is selected from all the conditions reported on a death certificate. 
Associated causes of death are all causes listed on the death certificate, other than the 
underlying cause of death. They include the immediate cause, any intervening causes, and 
conditions that contributed to the death but were not related to the disease or condition 
causing the death. 
Since deaths rarely have a single cause, analysis using multiple causes of death data (that is, 
the underlying cause of death and all associated causes of death) gives a more complete 
representation of all diseases and conditions that caused a death (AIHW 2012).          
Acute kidney injury as the underlying or an 
associated cause of death 
In 2012, there were around 5,160 deaths where AKI was recorded as the underlying or an 
associated cause of death (3.5% of all deaths in 2012). Nine in 10 (90%) were for AKI as an 
associated cause of death.  
The majority (99%) of AKI deaths, as an underlying or associated cause, were coded as 
‘Acute kidney failure—unspecified’ (ICD-10 code N17.9).  
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Underlying causes of death where AKI is an associated cause of 
death 
When AKI was listed as an associated cause of death, diseases of the circulatory system  
(cardiovascular disease) were the leading underlying cause of death—26% of deaths (around 
1,210 deaths), followed by neoplasms (largely cancers; 18%; 850 deaths) and diseases of the 
genitourinary system (13%; almost 600 deaths) (Table 3.1).  
Table 3.1: Underlying causes of death where AKI is an associated cause of  
death, 2012 
Underlying cause of death Number of deaths Per cent 
Diseases of the circulatory system 1,209 26.0 
Neoplasms (mainly cancer) 847 18.2 
Diseases of the genitourinary system 596 12.8 
Diseases of the digestive system 389 8.4 
Diseases of the respiratory system 376 8.1 
Endocrine, nutritional and metabolic diseases 374 8.1 
Certain infectious and parasitic diseases 232 5.0 
Other 622 13.4 
Total 4,645 100.0 
Source: AIHW National Mortality Database. 
Relationship between AKI and CKD mortality 
Several studies have suggested that AKI and CKD are not distinct entities but interconnected 
syndromes (Chawla et al. 2014; Ricci et al. 2008). In 2012, there were around 1,910 deaths 
recorded in which AKI and CKD were present as the underlying and/or an associated cause 
of death. Of all AKI-related deaths (underlying and/or an associated cause), 37% also had 
CKD listed as a cause of death. For all CKD-related deaths, 12% also had AKI listed as a 
cause of death (Figure 3.1). 
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Note: The ICD-10 code N00 is an overlapping code for AKI and CKD, that is, it can be used to define AKI or CKD. As a result, this code was 
excluded from this analysis to avoid overestimating the number of deaths with AKI, CKD, and AKI and CKD together. 
Source: AIHW National Mortality Database. 
Figure 3.1: Deaths for persons with acute kidney injury and/or chronic kidney disease as the 
underlying and/or an associated cause of death, 2012  
Trends 
Between 2000 and 2012, there were around 60,770 deaths where AKI was listed as an 
underlying or associated cause of death. The number of deaths each year has remained 
similar over this period, an average of 4,670 deaths per year.   
Despite large increases in AKI hospitalisation rates (from 42 to 71 hospitalisations per 
100,000 between 2000–01 and 2012–13), age-adjusted AKI death rates have remained similar 
over this period (around 19–21 deaths per 100,000 population per year) (Figure 3.2).  
Over this period, the male AKI death rate consistently remained 1.6 times as high as that of 
females (27 compared with 17 per 100,000 per year, respectively). 
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Note: Age-standardised to the 2001 Australian population.  
Source: AIHW National Mortality Database. 
Figure 3.2: Trends in acute kidney injury deaths as the underlying or an associated cause, by sex, 
2000–2012 
Sex and age 
AKI deaths (as the underlying or an associated cause of death) increase sharply with age for 
both males and females. In 2012, the rate of AKI deaths doubled for each age group from  
65–69 to 80–84, and tripled between those aged 80–84 and 85 and over (see Appendix B: 
Table B4).  
Across all age groups, AKI death rates were higher among males than females. Overall, 
death rates were 1.4 times as high among males compared with females (23 and 16 per 
100,000 respectively; Figure 3.3). 
While AKI death rates were higher in males than females, a similar number of males and 
females died from AKI in 2012 (2,555 compared with 2,609, respectively). This is due to the 
fact that a higher proportion of the female population lives to older ages with most deaths 
occurring in these age groups. The majority of AKI deaths among females (around 1,490, or 
57%) occurred at age 85 and over compared with 42% (just over 1,060) of male deaths (see 
Table B3).   
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Note: See Appendix B: Table B4. 
Source: AIHW National Mortality Database. 
Figure 3.3: Acute kidney injury death as the underlying or an associated cause, by age and sex, 2012 
When AKI was examined separately as either an underlying or associated cause of death, a 
similar pattern was seen with higher rates among males and increasing with age. The 
exception was for females aged 85 and over, who had higher death rates than males for AKI 
as the underlying cause of death (73 compared with 65 per 100,000 population, respectively). 
Population groups 
Remoteness 
In 2008–2012, the rate of AKI deaths (as the underlying or an associated cause of death) was 
around 1.5 times as high in Very remote areas (28 per 100,000 population) when compared 
with all other areas: Major cities (21), Inner regional (19), Outer Regional (18) and Remote areas 
(19).  
AKI death rates among males were similar across all remoteness areas. However, for 
females, the rate of AKI deaths was much higher in Very remote areas when compared with 
all other areas; around 1.9 times as high (Figure 3.4). This suggests that the pattern for 
females was the driver for the overall higher rate in Very remote areas. 
Socioeconomic disadvantage 
In 2012, living in an area with socioeconomic disadvantage was associated with higher AKI 
death rates for both males and females—death rates were 1.3 times as high in the lowest 
socioeconomic group compared with the highest socioeconomic group (21 and 16 deaths per 
100,000, respectively) (Figure 3.4). Overall, males had higher death rates than females in all 
socioeconomic groups for AKI as the underlying or an associated cause of death.  
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Aboriginal and Torres Strait Islander people 
In 2008–2012, AKI was the underlying or associated cause of death for around 330 Aboriginal 
and Torres Strait Islander people in the 5 jurisdictions with adequate identification of 
Indigenous status. The AKI death rate for Indigenous Australians was 1.8 times as high as 
that for non-Indigenous Australians (35 compared with 19 per 100,000 population, 
respectively).  
The gap in AKI death rates between Indigenous and non-Indigenous Australians was 
considerably higher for females than males—AKI death rates for Indigenous females and 
males were 2.1 and 1.6 times as high, respectively, as their non-Indigenous counterparts 
(Figure 3.4). 
 
Notes 
1. Age-standardised to the 2001 Australian population.  
2. See Appendix B: Table B4. 
3. Refer to Appendix A for definitions of classifications for remoteness and socioeconomic groups.  
4. Data for Indigenous status is for NSW, QLD, WA, SA and NT (see Appendix A). 
5. Excludes deaths with no stated information on Aboriginal and Torres Strait Islander status. 
6. Data for socioeconomic status is for 2012 only. 
Source: AIHW National Mortality Database. 
Figure 3.4: Acute kidney injury deaths as the underlying or associated cause of death, by sex and 
selected population characteristics, 2008–2012 
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4  Discussion 
The primary aim of this report is to provide an overview of AKI and its impact in Australia 
by describing the contribution of AKI towards hospitalisations and deaths. The findings are 
based on information recorded in hospital records and on death certificates, using a defined 
set of ICD-10 codes. However, this may not fully capture all cases of AKI in Australia, as it is 
an under-recognised condition for which the clinical definition/diagnostic criteria are still 
evolving.  
This report has shown that AKI accounts for many hospitalisations and deaths and that the 
burden of this condition is not equally distributed across the Australian population. These 
inequalities were seen in relation to all population characteristics examined, namely sex, age, 
remoteness of residence, socioeconomic disadvantage and Indigenous status. 
The burden of AKI  
Between 2000–01 and 2012–13, age-standardised hospitalisations rates for AKI as a principal 
diagnosis have increased by 69%—an average annual increase of 4%. Despite this large 
increase, AKI death rates have remained similar over this period. A potential contributor to 
the growth in AKI hospitalisations is an increase in the number of patients hospitalised who 
are susceptible to the disease due to surgery, sepsis, infections and greater use of kidney-
toxic medications (Siew & Davenport 2014).  
Hospitalisations 
In 2012–13, the average length of stay for AKI hospitalisations was twice as long as the 
average length of stay for hospitalisations overall (11.4 compared with 5.6 days, 
respectively).  
Hospitalisation rates for AKI as a principal diagnosis rise rapidly with age, with the majority 
occurring in those aged 65 and over. Males had substantially higher rates of AKI 
hospitalisations than females among the older age groups, while females had higher rates 
among those aged less than 55. The latter was due to high rates of ‘acute tubulo-interstitial 
nephritis’ (ICD-10-AM code N10) among younger women. This code includes 
pyelonephritis, the most common cause being urinary tract infections for which adult 
women are at 50 times higher risk than men (Masson et al. 2009). Other factors which may 
warrant further investigation to better understand the higher rates in young women include 
the presence of other conditions (for example a diagnosis of lupus), and use of particular 
medications damaging to the kidneys.  
AKI hospitalisation rates (as a principal diagnosis) were twice as high in Very remote areas 
than in Major cities. This may in part be due to the high rates of AKI hospitalisations for 
Indigenous Australians, where rates were 3 times as high as among Other Australians. AKI 
hospitalisation rates were also twice as high for those living in the lowest socioeconomic 
areas compared with the highest socioeconomic areas. 
Similar patterns were seen in hospitalisations with an additional diagnosis of AKI. Overall, 
AKI hospitalisations increase rapidly with age. AKI hospitalisation rates for people living in 
the lowest socioeconomic areas were 1.3 times as high as in the highest socioeconomic areas 
and they were twice as high among Indigenous Australians as for Other Australians. The 
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only difference between hospitalisations for AKI as the principal diagnosis compared with 
an additional diagnosis was that people living in Very remote areas or Major cities were 
hospitalised at similar rates, around 1.3 times, as those living in Inner regional, Outer regional 
and Remote areas. 
Deaths 
Similar to the pattern for hospitalisations, AKI death rates also rise rapidly with age, with the 
majority occurring in those aged 65 and over. Overall, AKI death rates for males were 1.4 
times as high as for females. People in Very remote areas had rates that were 1.5 times as high 
as people in Major cities, and rates among Indigenous Australians were nearly twice those of 
non-Indigenous Australians. People living in the lowest socioeconomic areas also had AKI 
death rates that were 1.3 times as high as people in the highest socioeconomic area.  
Interpretation of findings on health inequalities 
Each of the inequalities described above highlights areas where actions could be targeted to 
reduce AKI hospitalisations and deaths, bearing in mind overlaps among the population 
groups analysed here. For example, Very remote areas tend to have higher levels of 
socioeconomic disadvantage, and a higher proportion of the population that is Indigenous 
(AIHW 2014a).  
The disparity in AKI hospitalisation (as a principal diagnosis) and death rates by remoteness 
categories may reflect the higher proportion of Aboriginal and Torres Strait Islander people 
living in Remote and Very remote areas of Australia and their higher rates of CKD (AIHW 
2014a). In a previous AIHW report, it was found that Indigenous Australians accounted for 
54% of CKD hospitalisations as the principal diagnosis in Remote areas despite only making 
up 15% of the population (AIHW 2011). Recent studies have highlighted the 
interconnectedness between AKI and CKD; CKD is a predominant risk factor for AKI and 
AKI is a risk factor for the development of CKD (Chawla et al. 2014; Siew & Davenport 2014). 
However, the higher proportion of Indigenous Australians in remote areas is only one 
potential explanation for the higher AKI hospitalisation and death rates in Remote and Very 
remote areas, since other geographical, environmental and social factors can often contribute 
to the poorer health of people living in remote areas of Australia (AIHW 2014a).  
This report highlighted that AKI hospitalisation and death rates were considerably higher 
among Aboriginal and Torres Strait Islander people than other Australians, in particular 
Indigenous females. Previous studies have shown that there are higher rates of CKD and/or 
higher treated ESKD among Indigenous females compared with their male counterparts 
(AIHW 2011; Hoy et al. 2012). The reasons for this are complex and are likely to be 
influenced by several factors, including higher rates of diabetes and obesity in Indigenous 
females—both are key risk factors for CKD (Hoy et al. 2010; Hoy et al. 2012). This pattern of 
higher rates of CKD among Indigenous females may also contribute to the higher rates of 
AKI deaths and hospitalisations among females in Very remote areas.  
There is a complex interaction between the 3 health determinants described here: Indigenous 
status, remoteness and socioeconomic status, together with a myriad of other determinants 
covering aspects such as nutrition, tobacco use, alcohol consumption, a safe environment, 
education, employment, social support and housing. Access to and use of health services 
such as primary care, hospital emergency department and outpatient services, specialist care 
and community services, vary substantially across the 3 population groups described in this 
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report. All these factors can influence people’s health, increasing the risk of developing 
chronic conditions and associated complications, and consequently the risk of dying early. 
However, examining the effects of each factor independently was outside the scope of this 
report.  
What’s missing? 
Elements that were not examined in this report but may be worth pursuing if data were 
available are: 
• Prevalence and incidence of AKI—while individual studies examining the impact of AKI 
have been undertaken, there is a lack of reliable national data on the prevalence and 
incidence of AKI in Australia. 
• An assessment of the potential underestimation of AKI in hospital and deaths data, given 
that standardised definitions of AKI have only appeared in the last decade and AKI is 
clinically under-recognised (Lewington et al. 2013). 
• Patterns of hospitalisations for individuals with AKI using linked data. As previously 
noted, the hospital data in this report are based on episodes of admitted care which do 
not represent individuals.  
• Detailed hospitalisation analyses such as hospital-acquired AKI in the general 
hospitalised population and ICU.  
• The cause of gender differences in AKI hospitalisation rates (principal diagnosis) (as 
discussed above). 
• The financial cost and burden of AKI on individuals, the community and the health 
system. 
In addition, this report does not explain why inequalities exist, nor how socioeconomic, 
environmental and demographic factors interact to influence inequality. Further exploration 
and analysis of the social determinants of health could help to explain these relationships.  
Conclusion 
In conclusion, this first national report on AKI in Australia has shown that AKI is a growing 
problem that affects some groups in the population more than others. The impact of AKI on 
short- and long-term patient outcomes, and the escalating health-care costs and burden 
associated with the disease, highlight important and emerging challenges.  
AKI is a complex multifactorial syndrome, the clinical definition for which is still evolving. 
As the understanding and evidence base for AKI increases, it will then be possible to better 
capture the impact of AKI in Australia. Further research into the areas described above may 
assist with policy development, health-care planning and service provision and to improve 
the outcomes for people with AKI.  
 
  Acute kidney injury in Australia: a first national snapshot 23 
Appendix A: Data sources and methods 
Data sources 
National Hospital Morbidity Database 
The hospitalisation data in this report are sourced from the AIHW National Hospital 
Morbidity Database (NHMD), which is a compilation of episode-level records from admitted 
patient morbidity data collection systems in Australian hospitals. The NHMD is based on the 
Admitted Patient Care National Minimum Data Set (APC NMDS). It records information on 
admitted patient care (hospitalisations) in essentially all hospitals in Australia: all public and 
private acute and psychiatric hospitals, freestanding day hospital facilities and alcohol and 
drug treatment centres in Australia. Hospitals operated by the Australian Defence Force, 
corrections authorities and in Australia’s offshore territories are not in scope but some are 
included. It includes information on demographic characteristics, administrative and length-
of-stay data, as well as data on the diagnoses of the patients, the procedures they underwent 
in hospital and external causes of injury and poisoning.  
Reporting to the NHMD occurs at the end of a person’s admitted episode of care (separation 
or hospitalisation) and is based on the clinical documentation for that hospitalisation. 
Hospitalisations (separations) are reported to the NHMD in accordance with the 
requirements of the APC NMDS. The APC NMDS requires the principal diagnosis and any 
additional diagnoses to be reported according to the most recent edition of the International 
Statistical Classification of Diseases and Health Related Problems, 10th Revision, Australian 
Modification (ICD-10-AM) and associated Australian Coding Standards. 
The Indigenous status data in the NHMD for all states and territories were considered of 
sufficient quality for statistical reporting for 2012–13. The AIHW found that, for 2011–12, an 
estimated 88% of Indigenous patients were correctly identified in public hospitals. The 
overall quality of the data supplied for Indigenous status is considered to be in need of some 
improvement and this varied between states and territories.  
The hospital separations data do not include episodes of non-admitted patient care given in 
outpatient clinics or emergency departments. Patients in these settings may be admitted 
subsequently, with the care provided to them as admitted patients being included in the 
NHMD. The following care types were excluded when undertaking the analysis: 7.3 
(newborn—unqualified days only), 9 (organ procurement—posthumous) and 10 (hospital 
boarder). 
Most of the data used in this report were for the financial year 2012–13. Some trend 
information was also included from 2000–2001 to 2012–13. 
The data in this report were extracted from the AIHW NHMD in November 2014.  
Also see this link to National Hospital Morbidity Database Data Quality Statement: 
<http://meteor.aihw.gov.au/content/index.phtml/itemId/568730>. 
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National Mortality Database 
The Registries of Births, Deaths and Marriages, the Coroners and the National Coroners 
Information System provided the mortality data used in this report and the Australian 
Bureau of Statistics (ABS) carried out the coding. These data are maintained at the AIHW in 
the National Mortality Database. 
Indigenous analyses for 2010 have been adjusted for the additional deaths arising from 
outstanding registrations of deaths in Queensland in 2010. For more detail about the issue 
and the adjustments, please refer to the ABS Technical Note 3 in Causes of death, Australia, 
2010 (ABS cat. no. 3303.0). 
Deaths registered in 2010 and earlier are based on the final version of cause of death data; 
deaths registered in 2011 and 2012 are based on revised and preliminary versions, 
respectively and are subject to further revision by the ABS. 
The data quality statements underpinning the AIHW National Mortality Database can be 
found in the following ABS publications: ABS quality declaration summary for Causes of 
death, Australia (ABS cat. no. 3303.0) and the quality declaration summary for Deaths, 
Australia (ABS cat. no. 3302.0). 
Reporting AKI hospitalisations and deaths 
National Hospital Morbidity Database 
Australia uses the International Statistical Classification of Diseases and Related Health 
Conditions. For hospital diagnoses and procedures, a slightly different classification, 
modified for morbidity coding in Australia, is used—the International Statistical 
Classification of Diseases and Related Health Conditions, 10th Revision, Australian 
Modification (ICD-10-AM).  
The National Centre for Classification in Health (NCCH) developed the ICD-AM and it has 
been in use since 1998. It was developed with assistance from clinicians and clinical coders to 
ensure that the classification is current and appropriate for Australian clinical practice.  
ICD-10-AM is a derived version of the World Health Organization ICD-10. It uses an 
alphanumeric coding scheme for diseases and external causes of injury. It is structured by 
body system and aetiology, and comprises 3-, 4- and 5-character categories. ICD-10-AM is 
updated on a regular basis, with the regular updates of ICD-10 being included as part of the 
updating process (see AIHW 2014b and NCCH 2010 for more information). 
Details of the codes used for diagnosis for AKI and CKD in this report are listed in tables 
A1–2. Further, this report excludes AKI hospitalisations with a principal diagnosis of dialysis 
(109 hospitalisations). Dialysis patients require frequent treatment—normally 3 times per 
week for in-centre dialysis, mostly provided in hospitals. Given that the NHMD records 
episodes of admitted care and not individuals, a patient receiving dialysis would be counted 
as a separate hospitalisation each time they received treatment, potentially inflating the 
number of hospitalisations for AKI. Therefore, dialysis as a principal diagnosis for people 
admitted to hospital with AKI as an additional diagnosis has been excluded from the 
analysis in this report. 
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Table A1: ICD-10-AM codes used to define diagnosis groups for acute kidney injury, 2012–13  
Condition 
ICD-10-AM 
codes 
 Number (%)  
Principal diagnosis Additional diagnosis 
Principal and 
additional 
Acute nephritic syndrome N00 189 (1.1) 117 (0.1) 306 (0.2) 
Acute tubulo-interstitial nephritis N10 4,082 (22.7) 827 (0.7) 4,909 (3.7) 
Acute kidney failure(a) N17 13,353 (74.2) 87,144 (76.6) 100,497 (76.3) 
Diabetes with other specified 
kidney complication including 
acute kidney failure/impairment 
and medullary (papillary) 
necrosis 
E10.29 
E11.29 
E13.29 
E14.29 
331 (1.8) 24,689 (21.7) 25,020 (19.0) 
Postpartum acute kidney failure/ 
Kidney failure follow abortion  
and ectopic or molar pregnancy 
O90.4 
O08.4 10 (0.1) 89 (0.1) 99 (0.1) 
Post procedural kidney failure N99.0 43 (0.2) 902 (0.8) 945 (0.7) 
Total . . 18,008 (100.0) 113,768 (100.0) 131,776 (100.0) 
(a) 97% (97,291 cases) of N17 is N17.9 ‘Acute kidney failure, unspecified’; accounting for 74% of all AKI hospitalisations. 
Source: AIHW National Hospital Morbidity Database. 
 
Table A2: ICD-10-AM codes used to define diagnosis groups for chronic kidney disease  
Condition ICD-10-AM codes 
Diabetic nephropathy E10.2, E11.2, E13.2, E14.2 
Hypertensive kidney disease  I12, I13, I15.0, I15.1 
Glomerular diseases  N00–N08 
Kidney tubulo-interstitial diseases  N11, N12, N14, N15, N16 
Chronic kidney disease N18 
Unspecified kidney failure  N19 
Other disorders of kidney and ureter  N25–N28, N39.1, N39.2 
Congenital malformations  Q60–Q63 
Complications related to dialysis and kidney transplant  T82.4, T86.1 
Preparatory care for dialysis  Z49.0 
Kidney transplant and dialysis status  Z94.0, Z99.2 
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National Mortality Database 
Cause of death is coded according to rules set forward in various versions of the 
International Classification of Diseases (ICD) that the World Health Organization publishes. 
The relevant codes for deaths during the period covered by this report are provided in tables 
A3–4. 
Table A3: ICD-10 codes used to define diagnosis groups for acute kidney injury, 2012  
Condition 
ICD-10 
codes 
 Number (%)  
Underlying Associated 
Underlying and 
associated 
Acute nephritic syndrome N00 2 (0.4) 7 (0.2) 9 (0.2) 
Acute tubulo-interstitial nephritis N10 4 (0.8) 14 (0.3) 18 (0.3) 
Acute kidney failure(a) N17 513 (98.8) 4,591 (98.8) 5,104 (98.8) 
Postpartum acute kidney failure/ 
Kidney failure follow abortion  
and ectopic or molar pregnancy 
O90.4 
O08.4 0 (0.0) 0 (0.0) 0 (0.0) 
Post procedural kidney failure N99.0 0 (0.0) 33 (0.7) 33 (0.6) 
Total . . 519 (100.0) 4,645 (100.0) 5,164 (100.0) 
(a) 99% (5,054 cases) of N17 is N17.9 ‘Acute kidney failure, unspecified’; accounting for 98% of all AKI deaths. 
Source: AIHW National Mortality Database. 
 
Table A4: ICD-10 codes used to define diagnosis groups for chronic kidney disease  
Condition ICD-10-AM codes 
Diabetic nephropathy E10.2, E11.2, E12.2, E13.2, E14.2 
Hypertensive kidney disease  I12, I13, I15.0, I15.1 
Glomerular diseases  N00–N07 
Kidney tubulo-interstitial diseases  N11, N12, N14, N15 
Chronic kidney disease N18 
Unspecified kidney failure  N19 
Other disorders of kidney and ureter  N25–N28, N39.1, N39.2, E85.1, D59.3, B52.0 
Congenital malformations  Q60–Q63 
Complications related to dialysis and kidney transplant  T82.4, T86.1 
The relationship between AKI and CKD 
When examining the relationship between AKI and CKD in the NHMD (see Figure 2.1), the 
ICD-10-AM codes E10.29, E11.29, E13.29, E14.29 and N00 are overlapping codes for AKI and 
CKD; that is, they can be used to define AKI or CKD. As a result, these codes were excluded 
from this analysis to avoid overestimating the number of hospitalisations involving AKI, 
CKD, or AKI and CKD together. This resulted in 20,574 hospitalisations (27% of all 
hospitalisations with AKI or CKD as the principal or an additional diagnosis) being excluded 
from the analysis.  
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The excluded hospitalisations display similar sex, age, remoteness, socioeconomic and 
Indigenous distributions (data not shown) to the hospitalisations included in this analysis. 
Due to this, it is believed that the exclusion of these hospitalisations does not substantially 
impact on the results of this analysis.   
When examining the relationship between AKI and CKD in the NMD (see Figure 3.1), the 
ICD-10 code N00 is an overlapping code for AKI and CKD. Nine deaths coded to N00 were 
excluded which accounted for less than 1% of all deaths with AKI or CKD as an underlying 
or an associated cause of death. 
Remoteness 
Comparisons of regions in this report use the Australian Statistical Geography Standard 
(ASGS) 2011 Remoteness Structure, developed by the ABS, which groups Australian regions 
into 6 remoteness areas. The 6 remoteness areas are Major cities, Inner regional, Outer regional, 
Remote, Very remote and Migratory. These areas are defined using the 
Accessibility/Remoteness Index for Australia (ARIA). ARIA is a measure of the remoteness 
of a location from the services that large towns or cities provide. Accessibility is based on 
distance to a metropolitan centre. A higher ARIA score denotes a more remote location. The 
category Major cities includes Australia’s capital cities, with the exceptions of Hobart and 
Darwin, which are classified as Inner regional. The sixth Remoteness Area, Migratory, is not 
used in this publication. 
Further information on the ASGS is available on the ABS website at: 
<http://www.abs.gov.au/websitedbs/d3310114.nsf/home/australian+statistical+geograph
y+standard+(asgs)>. 
Socioeconomic disadvantage 
The ABS has constructed a number of socioeconomic indexes to classify areas on the basis of 
social and economic information collected in the Census of Population and Housing. In this 
report, the Socio-economic Indexes for Areas (SEIFA) Index of Relative Socio-economic 
Disadvantage (IRSD) is used. This is derived from social and economic characteristics of the 
local area such as low income, low educational attainment, high levels of public-sector 
housing, high unemployment and jobs in relatively unskilled occupations. 
Since the IRSD summarises variables that indicate disadvantage, a low score indicates that 
an area has many low-income families, many people with little training and many people 
working in unskilled occupations; and this area may be considered as disadvantaged relative 
to other areas. It is important to understand that a high score reflects a relative lack of 
disadvantage rather than advantage, and that the IRSD relates to the average disadvantage 
of all people living in a geographical area. Thus it cannot be presumed to apply to all 
individuals living within the area. As the population of many areas covers a broad range of 
socioeconomic disadvantage, these measures will generally underestimate the true effect of 
disadvantage on health. 
For analysis, the population was divided into 5 socioeconomic status (SES) groups with 
roughly equal populations (each around 20% of the total) based on the level of disadvantage 
of the statistical local area of their usual residence. The first group includes the 20% of the 
population living in areas with the highest levels of relative disadvantage (lowest SES), while 
the last group includes the 20% of the population living in areas with the lowest levels of 
relative disadvantage (highest SES). 
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The SEIFA IRSD values used in this report are based on the 2011 Census. Further 
information is available on the ABS website at: 
<http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/2033.0.55.0012011?OpenDocu
ment>. 
Aboriginal and Torres Strait Islander status 
When reporting data by Aboriginal and Torres Strait Islander status the terminology differs 
between the NHMD and the NMD due to the way the data are collected in the 2 data 
sources:  
• The NHMD—Indigenous Australians are compared with ‘Other Australians’ which 
includes people who did not identify as being of Aboriginal and/or Torres Strait 
Islander origin, and people for whom information on their Indigenous status was not 
available. 
• The NMD—Indigenous Australians are compared with ‘non-Indigenous’ Australians 
for the 5 jurisdictions (NSW, QLD, WA, SA and NT) with adequate identification of 
Indigenous status. 
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Appendix B: Detailed statistical 
tables/figure 
Table B1: Acute kidney injury hospitalisations, by principal and additional diagnosis, sex and 
selected population characteristics, 2012–13 
  Number 
  Principal diagnosis   Additional diagnosis 
Population characteristics Males Females Persons(a)  Males Females Persons(a) 
Age group (years)        
0–44 956 2,808 3,764  3,866 3,163 7,029 
45–54 596 701 1,297  3,975 2,404 6,379 
55–64 1,200 976 2,176  7,895 4,565 12,460 
65–74 1,891 1,358 3,249  14,011 8,589 22,600 
75–84 2,313 1,981 4,294  20,504 15,642 36,146 
85+ 1,519 1,709 3,228  13,464 15,690 29,154 
Total 8,475 9,533 18,008  63,715 50,053 113,768 
Socioeconomic group        
Group 1 (lowest SES) 2,181 2,442 4,623  15,962 12,740 28,702 
Group 2 1,875 2,069 3,944  13,698 10,665 24,363 
Group 3 1,714 1,895 3,609  13,076 10,211 23,287 
Group 4 1,443 1,604 3,047  11,365 9,008 20,373 
Group 5 (highest SES) 1,155 1,373 2,528  8,854 6,864 15,718 
Remoteness        
Major cities 5,534 6,286 11,820  45,134 37,072 82,206 
Inner regional 1,780 1,921 3,701  12,075 8,502 20,577 
Outer regional 914 956 1,870  5,156 3,502 8,658 
Remote 114 143 257  600 426 1,026 
Very remote 86 126 212  409 333 742 
Aboriginal and Torres Strait Islander status        
Indigenous 284 519 803  1,391 1,493 2,884 
Other Australians 8,191 9,014 17,205  62,324 48,560 110,884 
(a) Males and females may not add up to persons due to missing sex data. 
Source: AIHW National Hospital Morbidity Database. 
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Table B2: Acute kidney injury hospitalisation rates, by principal and additional diagnosis, sex and 
selected population characteristics, 2012–13 
  Hospitalisations per 100,000 population 
  Principal diagnosis   Additional diagnosis 
Population characteristics Males Females Persons  Males Females Persons 
Age group (years)        
0–44 13.5 40.8 27.0  54.7 46.0 50.4 
45–54 39.2 45.3 42.3  261.7 155.4 208.0 
55–64 92.8 74.0 83.3  610.3 346.2 477.0 
65–74 209.8 147.3 178.2  1,554.8 931.5 1,239.6 
75–84 498.4 353.8 419.3  4,418.1 2,793.7 3,529.9 
85+ 985.0 610.5 743.6  8,731.1 5,605.1 6,715.5 
Total age-standardised rate(a) 72.4 73.3 71.6  547.0 345.7 436.4 
Socioeconomic group(a)        
Group 1 (lowest SES) 91.9 96.3 92.9  666.0 440.8 543.3 
Group 2 75.6 77.7 75.5  552.8 354.2 444.4 
Group 3 71.8 71.6 70.4  548.0 345.8 437.4 
Group 4 66.6 62.5 63.3  533.4 328.9 420.0 
Group 5 (highest SES) 52.6 52.8 51.4  410.5 238.7 313.5 
Rate ratio (lowest/highest) 1.7 1.8 1.8  1.6 1.8 1.7 
Remoteness(a)        
Major cities 71.2 68.3 68.3  585.5 367.9 463.9 
Inner regional 71.9 77.0 73.5  482.0 289.4 377.6 
Outer regional 78.5 85.1 81.0  437.6 278.0 354.0 
Remote 70.0 99.4 83.1  385.8 298.8 342.7 
Very remote 90.4 156.5 119.4  470.5 448.8 454.6 
Rate ratio (Very remote/Major cities) 1.3 2.3 1.7  0.8 1.2 1.0 
Aboriginal and Torres Strait Islander status(a)        
Indigenous 158.1 229.3 195.6  889.8 846.9 865.7 
Other Australians 71.0 70.2 69.4  542.2 337.1 429.4 
Rate ratio (Indigenous/Other Australians) 2.2 3.3 2.8  1.6 2.5 2.0 
(a) Age-standardised to the 2001 Australian Standard Population. 
Source: AIHW National Hospital Morbidity Database. 
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Table B3: Acute kidney injury deaths (as the underlying or an associated cause), by sex and 
selected population characteristics 
 Number 
Year(s) Population characteristics Males Females Persons 
2012 Age group (years)    
 0–64 272 175 447 
 65–69 144 106 250 
 70–74 214 133 347 
 75–79 363 263 626 
 80–84 499 441 940 
 85 and over 1,063 1,491 2,554 
 Total 2,555 2,609 5,164 
2012 Socioeconomic group    
 Group 1 (lowest SES) 606 587 1,193 
 Group 2 564 576 1,140 
 Group 3 546 548 1,094 
 Group 4 435 451 886 
 Group 5 (highest SES) 394 443 837 
2008–2012 Remoteness    
 Major cities 8,949 9,176 18,125 
 Inner regional 2,567 2,390 4,957 
 Outer regional 1,098 966 2,064 
 Remote 128 108 236 
 Very remote 79 77 156 
2008–2012 Aboriginal and Torres Straits Islander status(a)(b)(c)    
 Indigenous 154 180 334 
 Non-Indigenous 8,772 8,428 17,200 
(a) These data have been adjusted for the additional deaths arising from outstanding registrations of deaths in Queensland in 2010. For more 
detail, please refer to Technical note 3 in Causes of death, Australia, 2010 (ABS Cat. no. 3303.0). 
(b) The analysis by Indigenous status includes data from NSW, QLD, WA, SA and NT only. 
(c) Excludes deaths with no stated information on Aboriginal and Torres Strait Islander status. 
Source: AIHW National Mortality Database. 
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Table B4: Acute kidney injury death rates (as the underlying or an associated cause), by sex and 
selected population characteristics 
 Deaths per 100,000 population 
Year(s) Population characteristics Males Females Persons 
2012 Age group (years)    
 0–64 2.8 1.8 2.3 
 65–69 28.3 20.6 24.4 
 70–74 57.7 34.6 45.9 
 75–79 135.9 86.1 109.3 
 80–84 259.0 174.3 210.9 
 85 and over 723.7 545.4 607.7 
 Total age-standardised rate(a) 23.2 16.2 19.2 
2012 Socioeconomic group(a)    
 Group 1 (lowest SES) 24.8 17.4 20.6 
 Group 2 23.3 16.9 19.7 
 Group 3 24.7 17.1 20.3 
 Group 4 22.0 15.2 18.0 
 Group 5 (highest SES) 20.0 13.7 16.4 
 Rate ratio (lowest/highest) 1.2 1.3 1.3 
2008–2012 Remoteness(a)    
 Major cities 25.7 17.0 20.6 
 Inner regional 23.1 15.2 18.5 
 Outer regional 21.7 15.0 17.9 
 Remote 21.6 17.1 19.2 
 Very remote 27.1 28.9 28.1 
 Rate ratio (Very remote/Major cities) 1.1 1.7 1.4 
2008–2012 Aboriginal and Torres Straits Islander status(a)(b)(c)(d)    
 Indigenous 38.6 33.5 35.4 
 Non-Indigenous 24.2 15.7 19.2 
 Rate ratio (Indigenous/non-Indigenous) 1.6 2.1 1.8 
(a) Age-standardised to the 2001 Australian population. 
(b) These data have been adjusted for the additional deaths arising from outstanding registrations of deaths in Queensland in 2010.  
For more detail, please refer to Technical note 3 in Causes of death, Australia, 2010 (ABS Cat. no. 3303.0). 
(c) The analysis by Indigenous status includes data from NSW, QLD, WA, SA and NT only. 
(d) Excludes deaths with no stated information on Aboriginal and Torres Strait Islander status. 
Source: AIHW National Mortality Database. 
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Including acute interstitial nephritis (ICD-10-AM code N10) 
 
 
Excluding acute interstitial nephritis (ICD-10-AM code N10) 
 
Note: Age-standardised to the 2001 Australian population. 
Source: AIHW National Hospital Morbidity Database. 
Figure B1: Trends in AKI hospitalisations as the principal diagnosis, including and excluding acute 
interstitial nephritis (ICD-10-AM code N10), by sex, 2000–01 to 2012–13  
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Acute kidney injury in Australia
A first national snapshot
Acute kidney injury (AKI) is increasing in incidence 
globally. This report presents the first national statistical 
snapshot on AKI and its impact in Australia. The key 
findings show that AKI accounts for a considerable 
number of hospitalisations and deaths and further, that 
the burden of this condition is not equally distributed 
across the Australian population. These inequalities 
were seen in relation to all population characteristics 
examined, namely sex and age, remoteness of residence, 
socioeconomic disadvantage and Indigenous status.
